DU 1227

Known as: DU-1227 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1989
024619861989

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
To elucidate the antihypertensive mechanisms of alacepril (DU-1219), the drug itself and its metabolites, desacetylalacepril (DU… (More)
Is this relevant?
1986
1986
Disposition and metabolism of 1-[(S)-3-acetylthio-2-methylpropanoyl]-L-prolyl-L-phenylalanine (alacepril, DU-1219) in rats were… (More)
Is this relevant?
1986
1986
To investigate the antihypertensive mechanism of 1-[(S)-3-acetylthio-2-methylpropanoyl]-L-prolyl-L-phenylalanine (alacepril, DU… (More)
Is this relevant?
1986
1986
The effects of 1-[(S)-3-acetylthio-2-methylpropanoyl]-L-prolyl-L-phenylalanine (alacepril, DU-1219), an orally active angiotensin… (More)
Is this relevant?
1986
1986
The fate of protein conjugate of desacetyl-alacepril (DU-1227) and its effect on angiotensin I converting enzyme (ACE) activity… (More)
Is this relevant?
1986
1986
The effects of 1-[(S)-3-acetylthio-2-methylpropanoyl]-L-prolyl-L-phenylalanine (alacepril, DU-1219) an antihypertensive compound… (More)
Is this relevant?
1986
1986
Tissue levels, tissue angiotensin I converting enzyme (ACE) inhibition and hypotension were examined 20 min, 1, 5 and 14 h after… (More)
Is this relevant?